Blog
Educational material, comparison studies and publications on SPR and other related techniques for researchers.
-
Introducing flexible configuration packages for the Alto Digital SPR System
In today’s challenging economic climate, both biotechs and academic labs are navigating through tough times, particularly when it comes to securing funding for essential equipment and research initiatives. At Nicoya, we recognize the impact of these economic challenges and are committed to providing innovative solutions to support scientific progress. To address the economic hurdles faced […]
-
Hello Boston, Meet Nicoya.
We are super excited to introduce our new lab in Boston! Meet the dynamic team behind the launch and discover the capabilities of our innovative instruments. We’re thrilled to share some fantastic news from the heart of Boston’s biotech hub! Following the launch of our San Francisco Lab, Nicoya Lifesciences is excited to announce the […]
-
Helping scientists succeed in the Bay Area: Meet the team behind our new San Francisco lab
We’re excited to announce the opening of our brand-new lab facility in San Francisco! Meet the team behind this exciting development and explore how we’re supporting drug discovery in the Bay Area. Over the past decade, Nicoya has achieved new heights through relentless dedication and groundbreaking accomplishments. This year, we proudly announce yet another remarkable […]
-
Epitope characterization made easy: How Digital SPR redefines the antibody workflow
Galvanize your productivity with Alto’s epitope binning application: Pre-designed, intuitive, and sample-friendly. Early antibody discovery involves the screening of a large number of molecules to identify hits and narrow them down to more promising leads. Efficient epitope binning plays a key role in identifying high quality leads to inform the downstream development process, and label-free […]
-
From droplets to kinetics: Exploring the fundamentals of digital microfluidics and SPR
Alto™ leverages digital microfluidics technology to streamline SPR workflows by automating and miniaturizing kinetics assays. Not too long ago, the idea of digitizing lab experiments like we digitized computing would have been unthinkable. The advent of digital microfluidics (DMF), an automated and programmable fluid-handling technology, has made this possible by enabling the programming of discrete […]
-
Become an SPR expert with our 10 tips for success
From assay design to optimization, our top 10 tips will guide you to success! After months of researching various technologies, evaluating surface plasmon resonance (SPR) instruments on the market, and zeroing in on the one that best fits your experimental workflow, it’s now time to design your first experiment. But where do you start? Diligent […]
-
How does Digital SPR fit into early drug discovery?
Digital surface plasmon resonance (SPR) offers a more automated and versatile method for studying binding properties that determine lead quality and drug efficacy. Biomolecular interactions are at the heart of drug discovery as they promote the regulation and execution of biological processes in the body, and their characterization is critical to validating new targets and […]
-
Meet Sri: Nicoya’s SVP of Marketing and Product
With Sri’s energy, vision, and strategic direction, we’re ready to leap into the next chapter of our growth. One of the most exciting developments in our year so far has been the addition of Dr. Sriram Kumaraswamy as Senior Vice President of Marketing and Product at Nicoya. As we look to enhance global access to […]
-
Shaping the future of therapeutic antibodies with Digital SPR
We spent a week with innovators of antibody therapeutics to learn how we can enhance development from bench to bedside By Mike Piazza, Associate Director of Applications Development We recently had the opportunity to attend the Next Generation Antibody Therapeutics meeting in the mountain-backed town of Banff, Calgary, and it was undoubtedly an eye-opening experience […]
-
The future of biosimilars: How emerging technologies are paving the way
Next-generation methods that streamline biosimilar expression and characterization are imperative to lowering the cost of development and maximizing market growth. Biosimilars have delivered on their promise to cut costs, increase access, and improve patient lives. As highly similar successors to commercially-available biologics, they have transformed patient outcomes in the last several decades by treating diseases […]